GlassScriptPhysician profile
David A Tecchio
NPI 1427095868
$5,410.83
in general payments reported to CMS, 2019-2025
7 companies · $1,604 in 2025
The $1,604 reported for 2025 was more than what 94% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,046 · 2022: $241 · 2023: $1,006 · 2024: $513 · 2025: $1,604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,647 · Consulting Fee: $800 · Travel and Lodging: $539 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,646.72 |
| Consulting Fee | $800.00 |
| Travel and Lodging | $539.38 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Cardiovascular Systems Corporation | $3,029.20 | 2021-2024 | Virtuosaph Plus With Radial Indication |
| Intuitive Surgical, INC. | $981.47 | 2025 | |
| Abiomed | $664.69 | 2023-2025 | Impella |
| Edwards Lifesciences Corporation | $361.30 | 2021-2024 | Inspiris Resilia Aortic Valve |
| Medical Device Business Services, INC. | $137.01 | 2025 | Prolene |
| Atricure, INC. | $135.33 | 2024-2025 | Atriclip Laa Exclusion System |
| Abbvie INC. | $101.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tecchio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.